​

Fennec Pharmaceuticals (FENC) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Fennec Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$47.54M

Latest Revenue (Q)

$8.75M

Main Segment (Y)

Royalty

Fennec Pharmaceuticals Revenue by Period

Fennec Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31$47.54M123.69%
2023-12-31$21.25M1284.50%
2022-12-31$1.53M100.00%
2021-12-31--100.00%
2020-12-31$170.00K100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31-100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-12-31-100.00%
2007-12-31-100.00%
2006-12-31-100.00%
2005-12-31-100.00%
2004-06-30-100.00%
2003-06-30-100.00%
2002-06-30--100.00%
2001-06-30$0.66-2.94%
2000-06-30$0.68-

Fennec Pharmaceuticals generated $47.54M in revenue during NA 2024, up 123.69% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Fennec Pharmaceuticals Revenue by Quarter

DateRevenueChange
2025-03-31$8.75M10.42%
2024-12-31$7.92M13.64%
2024-09-30$6.97M-3.97%
2024-06-30$7.26M-71.38%
2024-03-31$25.38M160.68%
2023-12-31$9.73M49.42%
2023-09-30$6.51M95.94%
2023-06-30$3.33M98.27%
2023-03-31$1.68M9.25%
2022-12-31$1.53M100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31--100.00%
2020-12-31$170.00K100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31-100.00%
2008-12-31-100.00%
2008-09-30-100.00%
2008-06-30-100.00%
2008-03-31-100.00%
2007-12-31--

Fennec Pharmaceuticals generated $8.75M in revenue during Q1 2025, up 10.42% compared to the previous quarter, and up 89.89% compared to the same period a year ago.

Fennec Pharmaceuticals Revenue Breakdown

Fennec Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 20
Royalty$170.00K

Fennec Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 20: Royalty (100.00%).

Fennec Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
TRDAEntrada Therapeutics$210.78M$20.56M
ENTAEnanta Pharmaceuticals$67.64M$18.31M
FENCFennec Pharmaceuticals$47.54M$8.75M
RNACCartesian Therapeutics$38.91M$298.00K
IMRXImmuneering--
ZURAZura Bio--
SLSSELLAS Life Sciences Group--
EPRXEupraxia Pharmaceuticals--
CRBUCaribou Biosciences--
ASMBAssembly Biosciences-$9.42M
SGMTSagimet Biosciences--

FENC Revenue FAQ

What is Fennec Pharmaceuticals’s yearly revenue?

Fennec Pharmaceuticals's yearly revenue for 2024 was $47.54M, representing an increase of 123.69% compared to 2023. The company's yearly revenue for 2023 was $21.25M, representing an increase of 1284.50% compared to 2022. FENC's yearly revenue for 2022 was $1.54M, representing an increase of 100.00% compared to 2021.

What is Fennec Pharmaceuticals’s quarterly revenue?

Fennec Pharmaceuticals's quarterly revenue for Q1 2025 was $8.75M, a 10.42% increase from the previous quarter (Q4 2024), and a -65.52% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $7.92M, a 13.64% increase from the previous quarter (Q3 2024), and a -18.59% decrease year-over-year (Q4 2023). FENC's quarterly revenue for Q3 2024 was $6.97M, a -3.97% decrease from the previous quarter (Q2 2024), and a 7.05% increase year-over-year (Q3 2023).

What is Fennec Pharmaceuticals’s revenue growth rate?

Fennec Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 2996.94%, and for the last 5 years (2020-2024) was 27863.53%.

What are Fennec Pharmaceuticals’s revenue streams?

Fennec Pharmaceuticals's revenue streams in c 20 are Royalty

What is Fennec Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 20, the largest source of revenue of Fennec Pharmaceuticals was Royalty. This segment made a revenue of $170K, representing 100.00% of the company's total revenue.